Keyphrases
Leprosy
100%
Leprosy Patients
44%
Indonesia
37%
Surabaya
27%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
26%
Disability
25%
Mycobacterium Leprae
20%
Randomized Controlled Trial
20%
Mesenchymal Stem Cell-conditioned Medium
19%
Plantar Ulcer
19%
Risk Factors
19%
Growth Factors
16%
Erythema Nodosum Leprosum
14%
COVID-19
13%
Gresik
13%
Diffuse Lepromatous Leprosy
13%
Leprosy Reactions
11%
Healing
10%
Grade 2 Disability
10%
M. Lepromatosis
10%
Ulcer
10%
Bacterial Index
8%
Endemic Countries
8%
Gauze Dressing
8%
Outpatient Clinic
8%
Mycobacterium Lepromatosis
7%
Co-infection
7%
Phenolic Glycolipids
7%
Referral Center
6%
Conditioned Medium
6%
Hepar
6%
Lycopersicon Esculentum
6%
Double-blind Randomized Clinical Trial
6%
Prednisolone
6%
Health Sciences
6%
Sexual Health
6%
Cutaneous Wound Healing
6%
Herpes Zoster
6%
Resveratrol
6%
Amniotic Mesenchymal Stem Cells
6%
Blood Vein
6%
Skin Health
6%
Chemoprophylactic
6%
Single Center
6%
Multicenter Retrospective Study
6%
Leprosy Services
6%
Ig M
6%
Stem Cell Metabolites
6%
Coping Strategies
6%
Correlation Study
6%
Medicine and Dentistry
Diseases
29%
Randomized Controlled Trial
20%
Erythema Nodosum Leprosum
20%
Plantar Ulcer
19%
Mesenchymal Stem Cell
19%
COVID-19
19%
Infection
17%
Mycobacterium leprae
16%
Ulcer
16%
Retrospective Study
16%
Amnion
13%
Quality of Life
13%
Cross Sectional Study
13%
Lepromatous Leprosy
13%
Medical Record
11%
Public Health
11%
Outpatient
11%
Prevalence
10%
Pediatrics
9%
Polypharmacy
9%
Mixed Infection
8%
Mycobacteria
8%
Secondary Data
8%
Metabolite
7%
Immunity
7%
Stem Cell
7%
Patient Referral
6%
Lagophthalmos
6%
Peroneus Nerve Paralysis
6%
Immunoglobulin M Antibody
6%
Urticaria
6%
Disseminated Herpes Zoster
6%
Framycetin
6%
Physical Activity
6%
Personal Experience
6%
Placenta
6%
Alpha Tocopherol
6%
Lopinavir/Ritonavir
6%
Ascorbic Acid
6%
Adipose Tissue
6%
Neuropathy
6%
Disease Burden
6%
Primary Health Care
6%
Methotrexate
6%
Randomized Clinical Trial
6%
Prednisolone
6%
Erythema
6%
Adipocyte
6%
Mouth Infection
6%
DNA Sequence
6%
